Literature DB >> 6304444

alpha2-Adrenergic stimulation enhances growth hormone secretion in the dog: a presynaptic mechanism?

S G Cella, G B Picotti, E E Müller.   

Abstract

Intravenous administration of clonidine (CLO), (2,4 and 8/micrograms/Kg), a predominantly alpha 2-adrenergic receptor agonist, induced in unanesthetized dogs clear-cut and dose-related rises in plasma GH (cGH) levels. Pretreatment with the selective antagonist of alpha 1-adrenergic receptors prazosin (0.1 mg/Kg iv) left unaltered the cGH rise induced by 4/micrograms/Kg of CLO whilst blockade of alpha 2-adrenergic receptors by yohimbine (2.5 mg/Kg iv) completely prevented it. In dogs treated 24 h previously, with reserpine (0.5 mg/Kg iv), a depletor of brain catecholamine stores, CLO was ineffective to stimulate cGH release. These data indicate that in the dog the GH-releasing effect of CLO occurs via stimulation of alpha 2-adrenergic receptors and suggest that the latter are located presynaptically in relation to norepinephrine neurons.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304444     DOI: 10.1016/0024-3205(83)90400-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Endocrinological differentiation of primary hypothalamic and pituitary disease.

Authors:  E E Müller
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

2.  Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients.

Authors:  L H Price; D S Charney; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Increased growth hormone response to clonidine in 6-hydroxydopamine-treated rats.

Authors:  L J Siever; C Tamminga; A Pert
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Growth-hormone releasing factor and clonidine in children with constitutional growth delay. Evidence for defective pituitary growth hormone reserve.

Authors:  C Pintor; R Puggioni; V Fanni; S G Cella; A Villa; V Locatelli; E E Müller
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

Review 5.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.